Ved å oppgi dette kan du få bedre tilpasset innhold om du har formell helsefaglig kompetanse.
Våre nettsider benytter cookies. Dersom cookien ikke er nødvendig for at nettsiden vår skal fungere,
vil den ikke lagres på din enhet med mindre du samtykker til dette.
Les mer om cookies her.
Ikke satt ennå.
Velkommen til symposium arrangert av UCB Pharma den 21. oktober 2021, klokken 17:00-19:40.
Møtet arrangeres på Konferansesenteret på Grand Hotel, Oslo.
Etter møtet er det middag på Lafable, Nedre Vollgate 19 (ved Stortinget).
Det er begrenset plass for fysisk oppmøte, men det er også mulig å delta digitalt.
Main session: Therapeutic equivalence
17:00 – 17:30 | Keynote lecture: Are TNF-inhibitors therapeutically equivalent – and when is switching indicated?Josef Smolen (Vienna)
17:30 – 18:00 | Round table discussion: Implications for patient management in Norway. Participants:Josef Smolen (Vienna)Till Uhlig (Oslo)Marianne Wallenius(Trondheim)Bjørg Tilde Fevang (Bergen)
18:00 – 18:10 | Short break
Second session: Therapeutic Drug Monitoring (TDM)
18:10 – 18:30 | The role of TDM in rheumatology and beyondGuro Løvik Goll (Oslo)
18:30 – 18:40 | Q&A
19:00 Post-symposium dinner
Moderators: Tore K. Kvien and Espen A. Haavardsholm
Professor of Rheumatology at the University of Oslo from 1997 to end of 2019. Head of the Department of Rheumatology at Diakonhjemmet Hospital, Oslo, Norway, from 1994 to 2019. Professor emeritus and senior research advisor at Diakonhjemmet Hospital.
Professor in Rheumatology at Institute of Clinical Medicine, University of Oslo. Head of Research and Innovation & Consultant Rheumatologist at Diakonhjemmet Hospital, Division of Rheumatology and Research.
Photo: Nicolas Tourrenc, Diakonhjemmet Hospital
Josef Smolen is Professor Emeritus at the Medical University of Vienna, Austria. Josef Smolen received his MD degree from the University of Vienna, trained there in Immunology, Medicine and Rheumatology. Research fellow at the Arthritis Institute at the National Institute of Health, Bethesda, MD (Maryland) USA. 1989-2017 he was Chairman of 2nd. Department of Medicine at Hietzing Hospital. 1995-2018 Professor of Medicine and Chairman of the Division of Rheumatology at the Medical University of Vienna, where he also acted as Chairman of the Department of Medicine 3 from 2007-2018.
Specialist in rheumatology and senior physician at the Division of Rheumatology and Research, Diakonhjemmet Hospital in Oslo.
She has a long-standing interest in immunology, biologic medicines and immunogenicity. Guro Løvik Goll was clinical coordinator for Rheumatology in the NOR-SWITCH and NOR-DRUM studies, and currently leads the Nor-vaC study.
Senior consultant at the Dept. of Rheumatology, St. Olav's Hospital. Professor at Institute of Neuromedicine and Movement Science (INB), Norwegian University of Science and Technology, NTNU. Holds a special interest in pregnancy and rheumatic diseases.
Professor in Rheumatology at the University of Oslo, Norway. Consultant rheumatologist at Diakonhjemmet Hospital
Professor at the Department of clinical medicine, University of Bergen(MD, PhD). Consultant doctor of rheumatology.
Kjersti Bøe-WescheHCP Partner iPVU Norway Solution Lead Immunology Northern Europe kjersti.Boe-Wesche@ucb.comPhone+47 90631659
Hilde Pettersen Immunology Northern Europehilde.firstname.lastname@example.orgPhone:+47 90416241